Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
phenobarbital | barbiturate whose blood concentration may be monitored | The phenobarbital sample time is recorded after the most recent administration. | Objective | Drug levels - named analytes and exposure reports |
phenytoin | antiseizure medicine measured as free or total drug | The phenytoin result on the original report is explicitly labeled total. | Objective | Drug levels - named analytes and exposure reports |
plateau concentration during infusion | concentration that has stabilized during a maintained infusion | Plateau concentration during infusion was assessed against the documented rate history. | Assessment | Medication response, exposure and reconciliation |
plateaued | stopped changing appreciably | Reports that improvement plateaued after the first two weeks. | Subjective | Sequence, exposures and use of medicines |
platelet aggregation study | measurement of platelet response to selected activating agents | The platelet aggregation study was reviewed with recent antiplatelet exposure. | Objective | Coagulation, antibodies and hemostasis studies |
population pharmacokinetic model | model of typical drug disposition and its variation across people | The team documented which population pharmacokinetic model informed the estimate. | Assessment | Drug concentrations, exposure and assay interpretation |
posaconazole | azole antifungal whose formulation and timing matter for concentration review | The posaconazole report is filed with the formulation recorded in pharmacy history. | Objective | Drug levels - named analytes and exposure reports |
post-exertional symptom exacerbation | worsening of symptoms following physical or mental effort | The patient reports post-exertional symptom exacerbation the day after the longer outing. | Subjective | Activities, exposure and recovery history |
post-hold level | drug concentration measured after therapy was held | The post-hold level was recorded with the time elapsed since the last confirmed dose. | Assessment | Medication response, exposure and reconciliation |
postcoital | following sexual intercourse | Reports one episode of postcoital bleeding. | Subjective | Sequence, exposures and use of medicines |
postdialysis redistribution | concentration changes after dialysis as drug moves between body compartments | Postdialysis redistribution was considered when comparing early and later postdialysis draws. | Assessment | Medication response, exposure and reconciliation |
postdistributional | obtained after the initial distribution phase | Sampling time was reviewed before labeling the level postdistributional. | Assessment | Drug levels - exposure and pharmacokinetics |
posterior estimate | updated model estimate after incorporating observed data | The posterior estimate incorporated the verified sample timing. | Assessment | Drug concentrations, exposure and assay interpretation |
postoperative | after an operation | Reports postoperative nausea during the first evening at home. | Subjective | Sequence, exposures and use of medicines |
| after delivery | Reports postpartum pelvic heaviness when standing. | Subjective | Sequence, exposures and use of medicines | |
postural | associated with a change in body position | Reports postural lightheadedness when getting out of bed. | Subjective | Sequence, exposures and use of medicines |
| happened before another event | Reports that nausea preceded the first episode of vomiting. | Subjective | Sequence, exposures and use of medicines | |
precipitant | event that set off the episode | Heat exposure is a plausible precipitant of the symptoms. | Assessment | Clinical patterns and problem characterization |
prediction interval | range intended to cover a future observation under a specified model | The observed concentration was compared with the model's prediction interval. | Assessment | Drug concentrations, exposure and assay interpretation |
premenstrual | before a menstrual period | Describes a recurring premenstrual headache. | Subjective | Sequence, exposures and use of medicines |
prescribing cascade | a drug effect is interpreted as a new problem and treated with another medicine | Prescribing cascade was considered because the new symptom followed the first drug change. | Assessment | Medication response, exposure and reconciliation |
pretest probability | likelihood before the test result is considered | The exposure history informs the pretest probability. | Assessment | Infection, inflammation and evidence interpretation |
primidone | antiseizure medicine assessed separately from its phenobarbital metabolite | The laboratory reports both primidone and phenobarbital. | Objective | Drug levels - named analytes and exposure reports |
procainamide | antiarrhythmic whose active metabolite may also be measured | The procainamide and metabolite concentrations are shown separately. | Objective | Drug levels - named analytes and exposure reports |
prodrug | compound converted in the body to an active form | The prescribed product is a prodrug and the assay measures its metabolite. | Assessment | Medication exposure, response and adverse-effect reasoning |